
Willis Towers Watson (WTW) has been busy on the product front, rolling out the Radar AI Assistant for insurers and partnering with Sapien Software to support HR and deal intelligence needs around mergers and divestitures.
These launches come at a mixed moment for Willis Towers Watson’s stock. The share price is US$296.26, with a 7-day share price return of 2.83% after a softer 1-day move. However, the 30-day share price return is down 6.13% and the year-to-date share price return is down 9.2%. For longer term holders, the 1-year total shareholder return is down 10.83%. In contrast, the 3-year total shareholder return of 43% and 5-year total shareholder return of 29.34% point to gains over a wider horizon, suggesting recent weakness comes after a period of stronger compounding.
Scan beyond Willis Towers Watson and line up AI-focused peers using the hand-picked 39 profitable AI stocks that aren't just burning cash that already back their technology spend with real profits.
Willis Towers Watson’s shares have slipped this year while analyst targets and intrinsic value estimates sit meaningfully higher. Is that gap a real margin of safety, or just misplaced optimism on the spreadsheet?
On the most followed view of Willis Towers Watson, a fair value of $378.58 sits well above the last close at $296.26. This puts the focus squarely on whether the business can turn current AI promises into sustained earnings power under a 7.65% discount rate.
The main factor that needs to work as intended is the execution of the Propel AI Acceleration Plan and related automation efforts so that the targeted enterprise and segment margin levels are reached after the investment period.
The current valuation reflects how the market is assessing the potential impact of the targeted margin structure, AI related cost initiatives and ongoing capital returns on Willis Towers Watson’s share price.
See why 7 investors see Willis Towers Watson as 22% undervalued.
Result: Fair Value of $378.58 (UNDERVALUED)
Still, the narrative can crack if AI tools become commoditised, or if softer commercial insurance pricing and talent losses erode Willis Towers Watson’s fee power.
Find out about the key risks to this Willis Towers Watson narrative.
Mixed messages on Willis Towers Watson so far, or a clear signal hiding in plain sight. Act while the data is fresh and weigh both sides of the story with the 4 key rewards and 1 important warning sign.
Use fresh momentum from your Willis Towers Watson research and channel it into spotting new opportunities with the Simply Wall Street Screener before they move without you.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com